Boston Scientific Corporation (BSX): Stephen Mandel Opens New Position in Medical Device Firm [Yahoo! Finance]
Boston Scientific Corporation (BSX)
Last boston scientific corporation earnings: 4/29 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bostonscientific.com
Company Research
Source: Yahoo! Finance
Boston Scientific Corporation (NYSE:BSX) is a new addition to the 13F portfolio of Lone Pine Capital. Filings for the fourth quarter of 2025 show that the fund owned a little over 200,000 shares in the company. Boston Scientific develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, and single-use scopes used for diagnostic and therapeutic procedures. 7 Hot Growth Stocks to Invest in Right Now Boston Scientific Corporation (NYSE:BSX) beat Q1 estimates with $5.20 billion in revenue and $0.80 EPS, but the stock price experienced volatility because management lowered full-year 2026 guidance. Many hedge funds view this guidance cut, now projecting 6.5%–8% organic growth, as a strategic reset. By lowering the bar, management has cleared the way
Show less
Read more
Impact Snapshot
Event Time:
BSX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BSX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BSX alerts
High impacting Boston Scientific Corporation news events
Weekly update
A roundup of the hottest topics
BSX
News
- BSX DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important May 4 Deadline in Securities Class Action - BSXGlobeNewswire
- Polen Focus Growth Sold Its Stake in Boston Scientific (BSX) Over Competition Concerns [Yahoo! Finance]Yahoo! Finance
- Deadline Alert: Boston Scientific Corporation (BSX) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud LawsuitGlobeNewswire
- Bronstein, Gewirtz & Grossman LLC Urges Boston Scientific Corporation Investors to Act: Class Action Filed Alleging Investor HarmGlobeNewswire
- BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Management Allegedly Hid Weakening U.S. Electrophysiology Sales Trends: Levi & KorsinskyPR Newswire
BSX
Earnings
- 4/22/26 - In-Line
BSX
Sec Filings
- 4/29/26 - Form SCHEDULE
- 4/22/26 - Form 8-K
- 4/2/26 - Form EFFECT
- BSX's page on the SEC website